SCHEMBL19426682

SCHEMBL19426682

Cc1ccc(S(=O)(=O)CN=[N+]=[N-])cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ KMT2A Q03164 5/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ GAA P10253 1/20 0.45
▸ MAPT P10636 1/20 0.44
▸ ADAM17 P78536 1/20 0.44
▸ CTSK P43235 1/20 0.43
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA3 P07451 1/20 0.42
▸ CA6 P23280 1/20 0.42
▸ CA5A P35218 1/20 0.42
▸ CA7 P43166 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CA5B Q9Y2D0 1/20 0.42
▸ RECQL P46063 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18634031 0.83 PLCG1 (0.53) CYP3A4CYP2C9CYP2C19KMT2ACA12
SCHEMBL19695399 0.83 ALDH1A1 (0.60) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL27742205 0.82 PSIP1 (0.48) ALDH1A1KMT2AMAPTHSD11B1NPC1
SCHEMBL14445541 0.79 ALDH1A1 (0.59) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL2218966 0.76 ALDH1A1 (0.55) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL12189513 0.76 ALDH1A1 (0.55) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL27676339 0.74 ALDH1A1 (0.53) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL15445196 0.74 GAA (0.42) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL28435857 0.74 ALDH1A1 (0.44) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL16820901 0.74 ALDH1A1 (0.49) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265437-A1 RNAi Agents for Inhibiting Expression of Matrix Metalloproteinase 7 (MMP7), Compositions Thereof, and Methods of Use SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT 2023-08-24 — — US disclosed
US-20170283434-A1 NK1 ANTAGONISTS OPKO HEALTH INC (US) 2017-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170283434-A1 NK1 ANTAGONISTS HRH4, CRHR2, HRH2 ALDH1A1 1005/4885CYP3A4 880/4885CYP2C9 1322/4885
US-20230265437-A1 RNAi Agents for Inhibiting Expression of Matrix Metalloproteinase 7 (MMP7), Compositions Thereof, and Methods of Use MMP7, MMP1, MMP17 ALDH1A1 2042/4885CYP3A4 4596/4885CYP2C9 4327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback